Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607678798356) titled 'Comparative Study of Allopurinol and Febuxostat Effects in Hyperuricemia and Chronic Kidney Disease Patients Using Serum Asymmetric Dimethyl Arginine as an Endothelial Dysfunction Marker' on July 30.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Sealed opaque envelopes
Primary Sponsor: Mohamed Eldougdoug
Condition:
Kidney Disease
Kidney Disease
Intervention:
Allopurinol
Febuxostat
Recruitment Status: Not Recruiting
Phase: No...